[go: up one dir, main page]

PH12014501104A1 - Complex antibacterial composition for animals - Google Patents

Complex antibacterial composition for animals

Info

Publication number
PH12014501104A1
PH12014501104A1 PH12014501104A PH12014501104A PH12014501104A1 PH 12014501104 A1 PH12014501104 A1 PH 12014501104A1 PH 12014501104 A PH12014501104 A PH 12014501104A PH 12014501104 A PH12014501104 A PH 12014501104A PH 12014501104 A1 PH12014501104 A1 PH 12014501104A1
Authority
PH
Philippines
Prior art keywords
antibacterial composition
animals
complex
complex antibacterial
strain
Prior art date
Application number
PH12014501104A
Other versions
PH12014501104B1 (en
Inventor
Hong Wan-Pyo
Original Assignee
Shinil Biogen Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shinil Biogen Co Ltd filed Critical Shinil Biogen Co Ltd
Publication of PH12014501104A1 publication Critical patent/PH12014501104A1/en
Publication of PH12014501104B1 publication Critical patent/PH12014501104B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention relates to a complex antibacterial composition for animals, and more particularly, to a complex antibacterial composition containing enrofloxacin, trimethoprim, and sulfamethoxazole in a complex manner, thereby ensuring safe administration and also exhibiting remarkable effects on both a gram negative strain and a gram positive strain, pathogens of a bacterial digestive disease and a respiratory disease.
PH12014501104A 2011-12-02 2014-05-16 Complex antibacterial composition for animals PH12014501104B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020110128657A KR101396933B1 (en) 2011-12-02 2011-12-02 The composition of antibacterial complex for animal
PCT/KR2012/007595 WO2013081284A1 (en) 2011-12-02 2012-09-21 Complex antibacterial composition for animals

Publications (2)

Publication Number Publication Date
PH12014501104A1 true PH12014501104A1 (en) 2014-08-11
PH12014501104B1 PH12014501104B1 (en) 2014-08-11

Family

ID=48535699

Family Applications (1)

Application Number Title Priority Date Filing Date
PH12014501104A PH12014501104B1 (en) 2011-12-02 2014-05-16 Complex antibacterial composition for animals

Country Status (6)

Country Link
KR (1) KR101396933B1 (en)
CN (1) CN103945847B (en)
BR (1) BR112014013242A2 (en)
PH (1) PH12014501104B1 (en)
RU (1) RU2014120208A (en)
WO (1) WO2013081284A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104606207A (en) * 2015-02-09 2015-05-13 南京格耀生物科技有限公司 Application of sulfamethoxazole in preparing medicament for inhibiting tumor cell metastasis and diffusion
KR102489659B1 (en) 2020-07-20 2023-01-18 경북대학교 산학협력단 Composition of antimicrobial complex for animal comprising amphenicols and aminoglycosides

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR860000502B1 (en) * 1980-09-10 1986-05-02 후나이 야꾸힝 고오교 가부시끼 가이샤 Manufacturing method of tablet containing antimicrobial substance
US20070086954A1 (en) * 1998-11-23 2007-04-19 Miller Christopher C Method and apparatus for treatment of respiratory infections by nitric oxide inhalation
KR100371092B1 (en) * 1999-12-09 2003-02-05 주식회사대성미생물연구소 The composition of antibacterial complex for animal
CN101011402A (en) * 2007-02-06 2007-08-08 天津生机集团有限公司 Compound sulfadimidine sodium injection and its preparation method

Also Published As

Publication number Publication date
RU2014120208A (en) 2016-02-10
CN103945847B (en) 2016-04-13
CN103945847A (en) 2014-07-23
WO2013081284A1 (en) 2013-06-06
KR101396933B1 (en) 2014-05-21
BR112014013242A2 (en) 2017-06-13
PH12014501104B1 (en) 2014-08-11
KR20130062187A (en) 2013-06-12

Similar Documents

Publication Publication Date Title
MX2019009132A (en) Synergistic bacterial compositions and methods of production and use thereof.
MX2015006491A (en) Synergistic bacterial compositions and methods of production and use thereof.
NZ702663A (en) Nuclear transport modulators and uses thereof
HK1218560A1 (en) Compositions and methods
MX2015016983A (en) Nuclear transport modulators and uses thereof.
TN2015000278A1 (en) Autotaxin inhibitors
PH12014502744A1 (en) A pharmaceutical composition containing nicotinic acid and/or nicotinamide and/or tryptophan for positively influencing the intestinal microbiota
GB201106750D0 (en) Novel compounds
MX2013000369A (en) Treatment of lung infections by administration of tobramycin by aerolisation.
MX2015004362A (en) Ketamine derivatives.
PH12015501334A1 (en) Milk-based nutritional compositions containing lactoferrin and uses thereof
NZ701553A (en) Medicine comprising combination of general anesthetic drug and hydrogen
PH12014502071A1 (en) Beta-hydroxy-beta-methylbutyric acid for imrpoving glucose tolerance
PH12014501104A1 (en) Complex antibacterial composition for animals
AU2012386215A8 (en) Pharmaceutical composition of milk fat globules (MFGs) zinc free
MX2014006201A (en) Imatinib solid dosage forms reconstituted just before use.
MY170190A (en) Use of a fermented soy extract as a prebiotic composition
PH12015501428A1 (en) Antibacterial compounds
WO2013109202A3 (en) Pharmaceutical compounds comprising cefetamet
WO2014028999A8 (en) Essential oil microparticles and uses thereof for preventing enteric diseases
HK1229697A1 (en) Synergistic bacterial compositions and methods of production and use thereof
MX356969B (en) A reduced-cholesterol dairy product for use as a medicament.
UA108238C2 (en) ANTIBACTERIAL COMPOSITION
UA60002U (en) method for prevention of acute respiratory infections in young children
MY171941A (en) Pharmaceutical compositions